A
19.86
0.11 (0.56%)
| Previous Close | 19.75 |
| Open | 19.75 |
| Volume | 375,346 |
| Avg. Volume (3M) | 2,543,903 |
| Market Cap | 3,973,822,208 |
| Price / Earnings (Forward) | 263.16 |
| Price / Sales | 1.29 |
| Price / Book | 28.29 |
| 52 Weeks Range | |
| Earnings Date | 30 Oct 2025 |
| Profit Margin | -3.02% |
| Operating Margin (TTM) | -0.46% |
| Diluted EPS (TTM) | -0.470 |
| Quarterly Revenue Growth (YOY) | 47.50% |
| Total Debt/Equity (MRQ) | 302.31% |
| Current Ratio (MRQ) | 1.69 |
| Operating Cash Flow (TTM) | 57.62 M |
| Levered Free Cash Flow (TTM) | 85.46 M |
| Return on Assets (TTM) | -5.06% |
| Return on Equity (TTM) | -75.39% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Healthcare Plans (US) | Bullish | Bearish |
| Healthcare Plans (Global) | Bullish | Bearish | |
| Stock | Alignment Healthcare, Inc. | Bullish | Bullish |
AIStockmoo Score
0.6
| Analyst Consensus | 4.0 |
| Insider Activity | NA |
| Price Volatility | -1.5 |
| Technical Moving Averages | -2.5 |
| Technical Oscillators | 2.5 |
| Average | 0.63 |
|
Alignment Healthcare Inc is a next-generation, consumer-centric platform that is revolutionizing the healthcare experience for seniors through Medicare Advantage plans. These plans are marketed and sold direct-to-consumer, allowing seniors to select the manner in which customers receive healthcare coverage and services on an annual basis. The company combines a technology platform and clinical model for more effective health outcomes. |
|
| Sector | Healthcare |
| Industry | Healthcare Plans |
| Investment Style | Small Growth |
| % Held by Insiders | 5.54% |
| % Held by Institutions | 92.78% |
| 52 Weeks Range | ||
| Price Target Range | ||
| High | 30.00 (Piper Sandler, 51.06%) | Buy |
| Median | 24.00 (20.85%) | |
| Low | 21.00 (UBS, 5.74%) | Hold |
| Average | 24.75 (24.62%) | |
| Total | 3 Buy, 1 Hold | |
| Avg. Price @ Call | 21.52 | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| TD Cowen | 16 Jan 2026 | 25.00 (25.88%) | Buy | 22.50 |
| UBS | 14 Jan 2026 | 21.00 (5.74%) | Hold | 21.75 |
| Piper Sandler | 06 Jan 2026 | 30.00 (51.06%) | Buy | 21.30 |
| JP Morgan | 17 Dec 2025 | 23.00 (15.81%) | Buy | 20.55 |
| 24 Nov 2025 | 20.00 (0.70%) | Buy | 17.62 |
No data within this time range.
| Date | Type | Details |
|---|---|---|
| 05 Feb 2026 | Announcement | Alignment Healthcare to Announce Fourth Quarter and Full-Year 2025 Financial Results and Host Conference Call Thursday, Feb. 26, 2026 |
| 21 Jan 2026 | Announcement | Alignment Healthcare Named to the 2026 Fortune World’s Most Admired Companies™ List for First Time |
| 20 Jan 2026 | Announcement | Alignment Health Appoints Adnan Mansour as Chief Digital Officer to Accelerate AI-Driven Growth and Technology Leadership |
| 12 Jan 2026 | Announcement | Alignment Healthcare Reports 31% Year-Over-Year Membership Growth to 275,300 as of Jan. 1, 2026 |
| 17 Dec 2025 | Announcement | Alignment Healthcare to Present at the 44th Annual J.P. Morgan Healthcare Conference |
| 19 Nov 2025 | Announcement | Alignment Healthcare to Present at Piper Sandler 37th Annual Healthcare Conference |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |